EUCTR2005-002701-23-ATActive, not recruitingNot Applicable
Escitalopram versus Citalopram Treatment effects on cortical and subcortical activity assessed by pharmacological fMRI
Siegfried Kasper, O.Univ.Prof.Dr.Dr.h.c.0 sites18 target enrollmentStarted: October 7, 2005Last updated:
Conditions
Drugs
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
- Enrollment
- 18
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •Age 18 - 55 years.
- •Male or female healthy volunteers.
- •No history of drug or alcohol abuse.
- •Normal laboratory values.
- •Normotension (blood pressure less than 140/90).
- •No past or present history of psychiatric disorders or major medical illness.
- •Negative urine pregnancy test in women at the screening visit & prior to each fMRI
- •Signed informed consent form.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years)
- •F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- •Clinically relevant abnormalities on a general physical examination and routine laboratory screening.
- •Ingestion of any medication that might interfere with the study medication within 4 week prior to screening visit.
- •Family history of diabetes or obesity
Investigators
Similar Trials
Completed
Not Applicable
Comparative Effect of Citalopram and Escitalopram in the Patients with SchizophreniaSchizophreniaIRCT20190525043700N1Babol University of Medical Sciences60
Completed
Phase 2
Evaluation of the effect of Escitalopram versus placebo trial on changing the neuroticismeuroticism or neuroticism.Post-traumatic stress disorder, acuteF43.11IRCT20211208053331N1Ahvaz University of Medical Sciences172
Recruiting
Phase 3
Treatment of depressive symptoms in patients with heart failureDepression.Major depressive disorder, single episode, mildF32.0IRCT20190525043700N5Babol University of Medical Sciences80
Active, not recruiting
Phase 1
A Randomised Controlled Trial of Escitalopram and Nortriptyline compared with placebo, and standard psychological care, for depression in Parkinson’s diseaseDepression in Parkinson's diseaseMedDRA version: 20.0Level: PTClassification code 10012378Term: DepressionSystem Organ Class: 10037175 - Psychiatric disordersMedDRA version: 20.0Level: PTClassification code 10061536Term: Parkinson's diseaseSystem Organ Class: 10029205 - Nervous system disordersEUCTR2018-002942-35-GBniversity College London Comprehensive Clinical Trials Unit408
Recruiting
Phase 3
Effect of of escitalopram and relaxation on hot flashes of patients with breast cancerIRCT2017072834482N2Vice chancellor for Research, Kermanshah University of Medical Sciences87